BOSTON, Jan. 5, 2018 /PRNewswire/ -- LikeMinds, Inc. announced that its CEO, Peter Savas,will present at Biotech Showcase™ 2018 in San Francisco January 8–10.
Mr. Savas' update will cover LikeMinds' clinical and commercial development, capital formation and organization building accomplishments during
Fueled by an aging demographic, the prevalence and incidence of devastating, costly degenerative neurological diseases is becoming an epidemic. As a result, the demand for precision brain imaging in Europe, Japan and the US is accelerating. LikeMinds' mission is to provide physicians, academic researchers, drug companies and data scientists with an efficient, accurate, affordable brain imaging technology platform.
Following the presentation, members of the senior management team will be available for one-on-one meetings with investment professionals and business development representatives from the life sciences industry attending the Biotech Showcase conference.
Details for the LikeMinds presentation are:
Date: Monday, January 8, 2018Time: 9:45am (PST)Room: Franciscan B – Ballroom LevelVenue: Hilton San Francisco Union Square Hotel, 333 O'Farrell Street, San Francisco, CA (United States)
About LikeMindsBased in Boston, LikeMinds is a radiopharmaceutical product and technology development company that aims to provide a precise, early, accurate and ultimately actionable diagnosis of tremor, dementia and other dopamine-related brain diseases. The Company's DaT2020TM imaging agent product candidate is planned to complete a comparison trial to the existing competitor in mid-2018 and will enter FDA registration trials later in 2018.
About Biotech Showcase™Biotech Showcase™, produced by Demy-Colton and EBD Group, is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences, J.P. Morgan Annual Healthcare Conference.
Sara Demy-Colton, CEO of Demy-Colton, said: "We are delighted that Mr. Savas will be presenting LikeMinds at Biotech Showcase this year. Biotech Showcase is the perfect platform for life science companies to showcase their innovation and seek out their next deal. This year again we are thrilled to be hosting what we believe will be the great business development opportunity of 2018."
Company Contact:Victoria Zikopoulou617firstname.lastname@example.org
Investor Relations Contact:Ken Rice617email@example.com
Media Relations Contact:Erika BrownCerconeBrownCompany617.firstname.lastname@example.org
Additional links and information:Follow Biotech Showcase on Twitter: @EBDGroup and @Demy_Colton - #BiotechShowcase
View original content:http://www.prnewswire.com/news-releases/brain-imaging-company-likeminds-to-present-at-biotech-showcase-2018-300578299.html
SOURCE LikeMinds, Inc.
Subscribe to our Free Newsletters!
Abortion pills are used in the first trimester to terminate pregnancy. Women should be aware of ...
Tea tree oil is an essential oil derived from the leaves of the Melaleuca alternifolia plant and ...
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...View All